Toronto - Delayed Quote CAD
HLS Therapeutics Inc. (HLS.TO)
4.2300
+0.0600
+(1.44%)
At close: April 25 at 3:45:08 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
8,003
8,003
15,789
16,942
16,429
Investing Cash Flow
11,735
11,735
-189
-10,148
-4,510
Financing Cash Flow
-23,364
-23,364
-14,639
-6,856
-11,398
End Cash Position
17,456
17,456
21,952
20,723
21,179
Capital Expenditure
-15
-15
-189
-10,148
-4,510
Issuance of Debt
--
--
--
10,000
--
Repayment of Debt
-21,573
-21,573
-9,463
-10,441
-11,137
Repurchase of Capital Stock
-600
-600
-1,552
-998
-47
Free Cash Flow
7,988
7,988
15,600
6,794
11,919
12/31/2021 - 3/14/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LSL.V LSL Pharma Group Inc.
0.3500
+1.45%
CTX.TO Crescita Therapeutics Inc.
0.5700
0.00%
DHT-UN.TO DRI Healthcare Trust
11.34
+0.53%
GUD.TO Knight Therapeutics Inc.
5.90
+1.20%
MDP.TO Medexus Pharmaceuticals Inc.
2.7000
-2.53%
CPH.TO Cipher Pharmaceuticals Inc.
12.40
+3.33%
LOVE.V Cannara Biotech Inc.
1.4000
+1.45%
CRON.TO Cronos Group Inc.
2.5000
-2.34%
HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.6700
+3.08%
UPC Universe Pharmaceuticals INC
4.2000
+10.53%